E O Dillingham - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

E O Dillingham

Showing results (11-20 of 25) with videos related to

Pageof 3

Sort By:

Research Communications in Chemical Pathology and Pharmacology|October 1, 1987

Serotonin efflux-inducing effects on human blood platelets by carbamoylpiperidine and nipecotoylpiperazine aggregation inhibitorsA Lasslo, E O Dillingham, R Gollamudi, et al.

Journal of Biomedical Materials Research|November 1, 1983

Acrylate and methacrylate esters: relationship of hemolytic activity and in vivo toxicityE O Dillingham, W H Lawrence, J Autian, et al.

Biochemical and Biophysical Research Communications|June 14, 1991

Cytosolic ionized calcium in human platelets: the influence of collagen and a novel antiplatelet agentR Gollamudi, E O Dillingham, S E Bond, et al.

Research Communications in Chemical Pathology and Pharmacology|February 1, 1990

The effect of carbamoylpiperidine and nipecotoylpiperazine analogs on ADP-stimulated human thrombocyte aggregation and platelet factor 3 availabilityE O Dillingham, A Lasslo, R Gollamudi, et al.

Biochimica Et Biophysica Acta|February 24, 1989

Relationships between chemical structure and inhibition of ADP-stimulated human thrombocyte release of serotonin and platelet factor 4E O Dillingham, A Lasslo, G Carter-Burks, et al.

Research Communications in Chemical Pathology and Pharmacology|December 1, 1992

In vitro and in vivo activities of the novel antiplatelet agent alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromideB A Lyman, S E Bond, E O Dillingham, et al.

Thrombosis Research|February 15, 1993

Enantioselective antiplatelet actions of nipecotamidesR Gollamudi, Z Feng, E O Dillingham, et al.

General Pharmacology|April 1, 1997

Antiplatelet effects of R,S-(meso)-alpha, alpha'-bis[3-(N,N-diethylcarbamoyl) piperidino]-p-xylene ex vivo in the dog and in vivo in the mouseG Han, D Bannerman, R K Handa, et al.

General Pharmacology|November 1, 1994

Synergistic antiplatelet effects of a nipecotamide A-1C and low dose aspirinG Han, S E Bond, W H Lawrence, et al.

Biochimica Et Biophysica Acta|August 7, 1989

Relationships between chemical structure and inhibition of epinephrine-induced human blood platelet aggregationJ Petrusewicz, A Lasslo, G Carter-Burks, et al.

Pageof 3

Search research articles

Showing results (11-20 of 25) with videos related to

Sort By:

Pageof 3

Research Communications in Chemical Pathology and Pharmacology|October 1, 1987

Serotonin efflux-inducing effects on human blood platelets by carbamoylpiperidine and nipecotoylpiperazine aggregation inhibitorsA Lasslo, E O Dillingham, R Gollamudi, et al.

Journal of Biomedical Materials Research|November 1, 1983

Acrylate and methacrylate esters: relationship of hemolytic activity and in vivo toxicityE O Dillingham, W H Lawrence, J Autian, et al.

Biochemical and Biophysical Research Communications|June 14, 1991

Cytosolic ionized calcium in human platelets: the influence of collagen and a novel antiplatelet agentR Gollamudi, E O Dillingham, S E Bond, et al.

Research Communications in Chemical Pathology and Pharmacology|February 1, 1990

The effect of carbamoylpiperidine and nipecotoylpiperazine analogs on ADP-stimulated human thrombocyte aggregation and platelet factor 3 availabilityE O Dillingham, A Lasslo, R Gollamudi, et al.

Biochimica Et Biophysica Acta|February 24, 1989

Relationships between chemical structure and inhibition of ADP-stimulated human thrombocyte release of serotonin and platelet factor 4E O Dillingham, A Lasslo, G Carter-Burks, et al.

Research Communications in Chemical Pathology and Pharmacology|December 1, 1992

In vitro and in vivo activities of the novel antiplatelet agent alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromideB A Lyman, S E Bond, E O Dillingham, et al.

Thrombosis Research|February 15, 1993

Enantioselective antiplatelet actions of nipecotamidesR Gollamudi, Z Feng, E O Dillingham, et al.

General Pharmacology|April 1, 1997

Antiplatelet effects of R,S-(meso)-alpha, alpha'-bis[3-(N,N-diethylcarbamoyl) piperidino]-p-xylene ex vivo in the dog and in vivo in the mouseG Han, D Bannerman, R K Handa, et al.

General Pharmacology|November 1, 1994

Synergistic antiplatelet effects of a nipecotamide A-1C and low dose aspirinG Han, S E Bond, W H Lawrence, et al.

Biochimica Et Biophysica Acta|August 7, 1989

Relationships between chemical structure and inhibition of epinephrine-induced human blood platelet aggregationJ Petrusewicz, A Lasslo, G Carter-Burks, et al.

Pageof 3